vaccine candidate against COVID-19
Why Bharat Biotech’s nasal vaccine can be a practical option: Being an intranasal vaccine, BBV154 may produce local antibodies in the upper respiratory tract ...
indianexpress.com/article/lifestyle/health-specials/why-bharat-biotechs-nasal-vaccine-can-be-a-practical-option-8340924/
Bharat Biotech applies for market authorisation from DCGI for its intranasal COVID-19 vaccine
financialexpress.com/healthcare/covid-19/bharat-biotech-applies-for-market-authorisation-from-dcgi-for-its-intranasal-covid-19-vaccine/2663829/
Bharat Biotech finishes clinical trials of intranasal COVID-19 vaccine; Says it is safe and immunogenic
financialexpress.com/healthcare/covid-19/bharat-biotech-finishes-clinical-trials-of-intranasal-covid-19-vaccine-says-it-is-safe-and-immunogenic/2630636/
Bharat Biotech Says Intranasal Covid Vaccine Found Safe In Booster Trials: Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III ...
ndtv.com/india-news/bharat-biotech-says-intranasal-covid-vaccine-found-safe-in-booster-trials-3256783
Drug regulator’s nod sought for phase-3 study of intranasal Covid vaccine in 5-18 age group
financialexpress.com/health-3/drug-regulators-nod-sought-for-phase-3-study-of-intranasal-covid-vaccine-in-5-18-age-group/2662767/
Clinical data disclosure critical for Bharat Biotech COVID-19 intranasal vaccine success in India: GlobalData
financialexpress.com/healthcare/covid-19/bharat-biotech-covid-19-intranasal-vaccine-globaldata-health-news/2643708/
Bharat Biotech finishes trials for intranasal Covid vaccine: “Two separate and simultaneous clinical trials were conducted to evaluate BBV154 as a primary dose ...
hindustantimes.com/india-news/bharat-biotech-finishes-trials-for-intranasal-covid-vaccine-101660585158611.html
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics